Yoshikiyo Ito

834 total citations
41 papers, 571 citations indexed

About

Yoshikiyo Ito is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yoshikiyo Ito has authored 41 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 16 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yoshikiyo Ito's work include Chronic Myeloid Leukemia Treatments (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Yoshikiyo Ito is often cited by papers focused on Chronic Myeloid Leukemia Treatments (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Yoshikiyo Ito collaborates with scholars based in Japan. Yoshikiyo Ito's co-authors include Tomohiko Kamimura, Yong Chong, Toshihiro Miyamoto, Koichi Akashi, Shinji Shimoda, Nobuyuki Shimono, Takatoshi Aoki, Takanori Teshima, Koji Kato and Koichi Ohshima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Yoshikiyo Ito

39 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshikiyo Ito Japan 15 195 177 154 144 87 41 571
Tomohiko Kamimura Japan 19 195 1.0× 279 1.6× 359 2.3× 178 1.2× 87 1.0× 64 871
Yui Kimura Japan 11 154 0.8× 77 0.4× 91 0.6× 87 0.6× 29 0.3× 23 467
Wan‐Shik Shin South Korea 16 76 0.4× 129 0.7× 100 0.6× 249 1.7× 129 1.5× 37 583
Hee Joo Lee South Korea 14 212 1.1× 90 0.5× 32 0.2× 191 1.3× 41 0.5× 41 574
Haggai Bar‐Yoseph Israel 14 132 0.7× 65 0.4× 44 0.3× 290 2.0× 39 0.4× 39 906
Elena Riera Spain 11 219 1.1× 28 0.2× 34 0.2× 70 0.5× 34 0.4× 15 498
Teresa Tórtola Spain 14 329 1.7× 114 0.6× 10 0.1× 434 3.0× 46 0.5× 39 870
Khalid Ahmed Al‐Anazi Saudi Arabia 11 53 0.3× 64 0.4× 56 0.4× 153 1.1× 11 0.1× 37 378
Shigeki Misawa Japan 12 51 0.3× 32 0.2× 72 0.5× 80 0.6× 50 0.6× 50 455
Jyotsna Agarwal India 12 82 0.4× 33 0.2× 36 0.2× 143 1.0× 61 0.7× 37 548

Countries citing papers authored by Yoshikiyo Ito

Since Specialization
Citations

This map shows the geographic impact of Yoshikiyo Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshikiyo Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshikiyo Ito more than expected).

Fields of papers citing papers by Yoshikiyo Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshikiyo Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshikiyo Ito. The network helps show where Yoshikiyo Ito may publish in the future.

Co-authorship network of co-authors of Yoshikiyo Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshikiyo Ito. A scholar is included among the top collaborators of Yoshikiyo Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshikiyo Ito. Yoshikiyo Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ito, Yoshikiyo, Hidetoshi Ozawa, Toshihiro Miyamoto, et al.. (2023). IKZF1plus alterations are not associated with outcomes in Philadelphia‐positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL/MRD2008 trial. European Journal Of Haematology. 111(1). 103–112. 4 indexed citations
3.
Tokunaga, Masahito, Kimiharu Uozumi, Yasuko Sagara, et al.. (2023). A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan. Leukemia & lymphoma. 64(4). 865–873. 1 indexed citations
4.
5.
Miyamoto, Toshihiro, Tetsuya Eto, Naoyuki Uchida, et al.. (2021). Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008. International Journal of Hematology. 113(6). 815–822. 2 indexed citations
6.
Nakano, Nobuaki, Y Takatsuka, Ayumu Kubota, et al.. (2021). Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma. International Journal of Hematology. 113(6). 861–871. 2 indexed citations
7.
Mori, Yasuo, Kensuke Sasaki, Yoshikiyo Ito, et al.. (2020). Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study. Annals of Hematology. 100(1). 197–208. 4 indexed citations
8.
Sasaki, Kensuke, Kohta Miyawaki, Yuichiro Semba, et al.. (2019). A Fast and Accurate Diagnostic Method for Ph-like ALL Using the Ncounter System. Blood. 134(Supplement_1). 375–375. 3 indexed citations
9.
Yoshimitsu, Makoto, Shigeo Fuji, Atae Utsunomiya, et al.. (2019). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors. Biology of Blood and Marrow Transplantation. 26(4). 718–722. 3 indexed citations
10.
Chong, Yong, Shinji Shimoda, Noriko Miyake, et al.. (2017). Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis. Infection and Drug Resistance. Volume 10. 193–199. 9 indexed citations
11.
Takashima, Shuichiro, Toshihiro Miyamoto, Masanori Kadowaki, et al.. (2014). Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients. International Journal of Hematology. 100(2). 159–164. 6 indexed citations
12.
Chong, Yong, Shinji Shimoda, Yoshikiyo Ito, et al.. (2014). Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis. PLoS ONE. 9(1). e85210–e85210. 21 indexed citations
13.
Aoki, Takatoshi, et al.. (2013). Retrospective study on decision making for end-of-life care in terminal phase and end of life for patients with hematologic malignancy. Palliative Care Research. 8(2). 248–253. 1 indexed citations
14.
Kamimura, Tomohiko, et al.. (2013). High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib. International Journal of Hematology. 98(6). 694–701. 3 indexed citations
15.
Chong, Yong, et al.. (2012). Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies. Journal of Infection and Chemotherapy. 18(5). 741–746. 28 indexed citations
16.
Kamimura, Tomohiko, Toshihiro Miyamoto, Noriaki Kawano, et al.. (2012). Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 95(6). 725–730. 19 indexed citations
17.
Kamimura, Tomohiko, Yong Chong, & Yoshikiyo Ito. (2011). Continuous intravenous infusion of fentanyl for pain due to stomatitis, pharyngitis, and esophagitis after hematopoietic stem cell transplantation. Palliative Care Research. 6(2). 246–252. 1 indexed citations
18.
Chong, Yong, et al.. (2011). Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. International Journal of Infectious Diseases. 15(4). e277–e281. 58 indexed citations
19.
Tateishi, Takahisa, et al.. (2006). [Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain].. PubMed. 46(4). 254–60. 1 indexed citations
20.
Kanegane, Hirokazu, Yoshikiyo Ito, Koichi Ohshima, et al.. (2005). X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis. American Journal of Hematology. 78(2). 130–133. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohiko Kamimura Breakdown of academic impact, for papers by Yui Kimura Breakdown of academic impact, for papers by Wan‐Shik Shin Breakdown of academic impact, for papers by Hee Joo Lee Breakdown of academic impact, for papers by Haggai Bar‐Yoseph Breakdown of academic impact, for papers by Elena Riera Breakdown of academic impact, for papers by Teresa Tórtola Breakdown of academic impact, for papers by Khalid Ahmed Al‐Anazi Breakdown of academic impact, for papers by Shigeki Misawa Breakdown of academic impact, for papers by Jyotsna Agarwal
Rankless by CCL
2026